BILLERICA, Mass., Jan. 17, 2017 -- Entegris, Inc. (Nasdaq:ENTG), a leader in specialty chemicals and advanced materials solutions for the microelectronics industry, will release its financial results for the fourth quarter of 2016 before the opening of the market on Thursday, February 2, 2017. A teleconference with management is scheduled for the same day at 10:00 a.m. Eastern Time (ET).
Participants should dial 1-888-600-4869 or 1-913-312-0936, referencing confirmation code 4935351. Participants are asked to dial in 5 to 10 minutes prior to the start of the call. For a replay of the call, please Click Here using passcode 4935351. The replay will be available starting at 1:00 p.m. ET on Thursday, February 2 until Saturday, March 18 at 1:00 p.m.
The call can also be accessed live and on-demand from the Entegris website. Point your web browser to http://investor.entegris.com/events.cfm and follow the link to the webcast. The on-demand playback will be available for six weeks after the conclusion of the teleconference.
ABOUT ENTEGRIS
Entegris is a leader in specialty chemicals and advanced materials solutions for the microelectronics industry and other high-tech industries. Entegris is ISO 9001 certified and has manufacturing, customer service and/or research facilities in the United States, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea and Taiwan. Additional information can be found at www.entegris.com.
Steven Cantor VP of Corporate Relations T +1 978 436 6750 [email protected]


Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Italy Fines Apple €98.6 Million Over App Store Dominance
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 



